This study aimed to compare the analgesic efficacy of the external oblique intercostal fascial plane block (EOIPB) versus the rectus sheath block (RSB) for managing postoperative pain following paraumbilical hernioplasty.
Background: Paraumbilical hernia repair is a frequently performed surgical procedure, often associated with significant postoperative pain and delayed recovery, which are major concerns for patients. Objectives: This study aimed to compare the analgesic efficacy of the external oblique intercostal fascial plane block (EOIPB) versus the rectus sheath block (RSB) for managing postoperative pain following paraumbilical hernioplasty. Methods: This prospective, randomized, single-blinded study enrolled 60 patients, divided into two groups (EOIPB and RSB), each comprising 30 participants. Blocks were administered after general anesthesia and prior to surgery. Patient demographics (age, weight), surgical duration, pain scores (measured by Numeric Rating Scale - NRS), total postoperative morphine consumption, intraoperative fentanyl consumption, and hemodynamic parameters (mean arterial pressure - MAP and heart rate - HR) were assessed.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
30
After the induction of general anesthesia and approximately 15 minutes before the surgical incision, patients were randomly assigned to receive either the EOIPB (Group A) or the RSB (Group B).
Helwan university
Giza, Giza Governorate, Egypt
Total postoperative morphine consumption in milligrams during the first 24 hours after surgery
Total cumulative morphine requirement administered for postoperative analgesia during the first 24 hours following paraumbilical hernia repair surgery, measured in milligrams (mg).
Time frame: First 24 hours postoperatively
Number of participants experiencing block-related or postoperative complications within 3 months after surgery
Assessment of postoperative and block-related complications including local anesthetic toxicity, hematoma, infection, nausea/vomiting, respiratory depression, and other adverse events recorded during the follow-up period.
Time frame: 3 months after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.